Treatment of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to single therapy with prostaglandin analogue or topical beta blocker.
Drugs for miotics and glaucoma
Travoprost and Timolol reduce intraocular pressure (IOP) by complementary mechanisms of action. Travoprost is a prostaglandin analogue which reduces IOP by increasing trabecular outflow & uveoscleral outflow. Timolol is a non-selective beta adrenergic receptor blocker that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anesthetic (membrane stabilizing) activity. It lowers IOP by decreasing the formation of aqueous humor in the ciliary epithelium.
Instill one drop in the conjunctival sac of the affected eye(s) once daily at about the same time each day
No specific interaction was observed with Travast Plus eye drops.
Contraindications
Contraindicated in patients who are hypersensitive to Travoprost, Timolol or any of the components of this preparation. Precautions & Warnings
Like other topically applied ophthalmic agents, Travoprost and Timolol are absorbed systemically. Due to the beta-adrenergic component, timolol, the same types of cardiovascular and pulmonary adverse reactions as seen with systemic beta adrenergic blocking agents may occur.
Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. It should not be used during pregnancy. Use in lactation: Caution should be exercised when Travoprost + Timolol Maleate is administered to a nursing mother.
Incase of overdose with Travast Plus, treatment should be symptomatic.
Store in a cool, dry place, away from heat and direct light. Keep out of the reach of children. Do not use more than 4 weeks after opening the bottle.
Store in a cool, dry place, away from heat and direct light. Keep out of the reach of children. Do not use more than 4 weeks after opening the bottle.
.png&w=384&q=75)